BiomX Statistics
Total Valuation
BiomX has a market cap or net worth of $5.04 million. The enterprise value is $2.12 million.
Important Dates
The next estimated earnings date is Friday, May 15, 2026, before market open.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BiomX has 7.84 million shares outstanding. The number of shares has increased by 115.25% in one year.
| Current Share Class | 7.84M |
| Shares Outstanding | 7.84M |
| Shares Change (YoY) | +115.25% |
| Shares Change (QoQ) | +21.02% |
| Owned by Insiders (%) | 4.56% |
| Owned by Institutions (%) | 8.41% |
| Float | 6.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87
| Current Ratio | 0.87 |
| Quick Ratio | 0.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,546.00 |
Financial Efficiency
Return on equity (ROE) is -316.90% and return on invested capital (ROIC) is -114.13%.
| Return on Equity (ROE) | -316.90% |
| Return on Assets (ROA) | -78.85% |
| Return on Invested Capital (ROIC) | -114.13% |
| Return on Capital Employed (ROCE) | 5,187.92% |
| Weighted Average Cost of Capital (WACC) | 7.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.81M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BiomX has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.44% in the last 52 weeks. The beta is 1.03, so BiomX's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -93.44% |
| 50-Day Moving Average | 3.26 |
| 200-Day Moving Average | 6.06 |
| Relative Strength Index (RSI) | 23.29 |
| Average Volume (20 Days) | 405,120 |
Short Selling Information
The latest short interest is 78,198, so 1.00% of the outstanding shares have been sold short.
| Short Interest | 78,198 |
| Short Previous Month | 93,010 |
| Short % of Shares Out | 1.00% |
| Short % of Float | 1.27% |
| Short Ratio (days to cover) | 0.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -30.92M |
| Pretax Income | -36.19M |
| Net Income | -36.20M |
| EBITDA | -28.00M |
| EBIT | -30.92M |
| Earnings Per Share (EPS) | -$22.19 |
Full Income StatementBalance Sheet
The company has $4.36 million in cash and $1.44 million in debt, with a net cash position of $2.92 million or $0.37 per share.
| Cash & Cash Equivalents | 4.36M |
| Total Debt | 1.44M |
| Net Cash | 2.92M |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | -1.30M |
| Book Value Per Share | -12.50 |
| Working Capital | -804,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$26.39 million and capital expenditures -$2,000, giving a free cash flow of -$26.39 million.
| Operating Cash Flow | -26.39M |
| Capital Expenditures | -2,000 |
| Depreciation & Amortization | 2.92M |
| Net Borrowing | n/a |
| Free Cash Flow | -26.39M |
| FCF Per Share | -$3.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
